Garlic Supplement Dissolution Standards Clinical Trial Use Suggested
This article was originally published in The Tan Sheet
Executive Summary
Future clinical trials on garlic and cardiovascular disease should use supplements that pass U.S. Pharmacopeia dissolution standards for high allicin release, a researcher suggested at a National Institutes of Health conference June 12 in Bethesda, Md.